Syndax Pharmaceuticals
SNDX
SNDX
215 hedge funds and large institutions have $1.3B invested in Syndax Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 89 increasing their positions, 60 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
215
Holders Change
+5
Holders Change %
+2.38%
% of All Funds
2.86%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.11%
New
36
Increased
89
Reduced
60
Closed
29
Calls
$19.4M
Puts
$6.29M
Net Calls
+$13.1M
Net Calls Change
+$11.8M
Top Buyers
Top Sellers
| 1 |
EP
1
Eversept Partners
New York
|
$4.54M |
| 2 |
O
2
OrbiMed
New York
|
$0 |
| 3 |
ACA
3
Avoro Capital Advisors
New York
|
$30.1M |
| 4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$0 |
| 5 |
CC
5
Commodore Capital
New York
|
$0 |
